James D. Best

17.1k citations
241 papers · 13.2k indexed · 2 hit papers · h-index 56

Impact in

Papers in

    • Diabetes, Cardiovascular Risks, and Lipoproteins 41
    • Diabetes Management and Research 36
    • Diabetes Management and Education 24
    • Diabetes Treatment and Management 23
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 16

James D. Best

233 papers receiving 12.6k citations

Hit Papers

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial 2005 · 2.4k citations
2.4k200420262011201850010001.5k2.0k

Peers

James D. Best
Comparison fields: 5 of 187
  • Endocrinology, Diabetes and Metabolism 5.2k
  • Cardiology and Cardiovascular Medicine 2.4k
  • Cancer Research 1.3k
  • Surgery 3.7k
  • Nephrology 585
Replace Paul N. Hopkins with:
Paul N. Hopkins United States
Margo A. Denke United States
Peter Almgren Sweden
Dominique Arveiler France
Jean‐Charles Fruchart France
Gloria Lena Vega United States
Christopher D. Byrne United Kingdom
Alicia J. Jenkins Australia
Khosrow Adeli Canada
Dimitri P. Mikhailidis United Kingdom
James D. Best relative to Paul N. Hopkins United States Paul N. Hopkins's profile →
Citations per field
00.5×1.5×
Paul N. Hopkins · 1×
Citations per year

Countries citing papers authored by James D. Best

Since Specialization
Citations

This map shows the geographic impact of James D. Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Best more than expected).

Fields of papers citing papers by James D. Best

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Best. The network helps show where James D. Best may publish in the future.

Co-authors

The 25 scholars most cited alongside James D. Best, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James D. Best Line = papers co-authored together James D. Best links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20187
2 201623
3
Reflection on the Development of a Research Agenda in Rural Health
20157
4 20138
5 201224
6
Predictors of peripheral neuropathy and effects of fenofibrate among 9,795 subjects with type 2 diabetes: the fenofibrate intervention and event lowering in diabetes (FIELD) study
20110
7
EFFECT OF FENOFIBRATE ON AMPUTATION EVENTS IN PEOPLE WITH TYPE 2 DIABETES MELLITUS (FIELD STUDY): A PRESPECIFIED ANALYSIS OF A RANDOMISED CONTROLLED TRIAL
20111
8 200633
9 200635
10
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand
200555
11 2003156
12
Lipid Management Guidelines -2001
200171
13
Multicentre randomised controlled trial of coaching patients on achieving cardiovascular health (COACH): a proven method for achieving risk factor targets in patients with coronary heart disease
20011
14 199831
15
A multicenter double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesteremia
19971
16
Atorvastatin and simvastatin reduce elevated cholesterol in non-insulin dependent diabetes
199632
17 198915
18 19882
19 19855
20
Lesson plan for self-treatment in hemophilia.
19771

About James D. Best

James D. Best is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Family Practice, Cardiology and Cardiovascular Medicine and Pharmacy, having authored 241 papers that have together received 13.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (41 papers), Diabetes Management and Research (36 papers), Metabolism, Diabetes, and Cancer (30 papers), Lipoproteins and Cardiovascular Health (28 papers), Diabetes Management and Education (24 papers), Diabetes Treatment and Management (23 papers), Pancreatic function and diabetes (18 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.2k citations), Cardiology and Cardiovascular Medicine (2.4k citations), Cancer Research (1.3k citations), Surgery (3.7k citations) and Nephrology (585 citations). James D. Best has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include Suzanne Rogers, Maria L. Macheda, Jeffrey B. Halter, Alicia J. Jenkins, David Sullivan, Michael C dʼEmden, R. John Simes, Kevin Rowley, Peter G. Colman and Philip J. Barter. Their work appears in journals such as Diabetes, Diabetes Care, The Medical Journal of Australia, American Journal of Physiology-Endocrinology and Metabolism and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026